Differential effects of chlorthalidone Versus spironolactone on muscle sympathetic nerve activity in hypertensive patients

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 4, 2009, Pages 1361-1366

  Menon, Dileep V ^a   Arbique, Debbie ^a   Wang, Zhongyun ^a   Adams Huet, Beverley ^a   Auchus, Richard J ^a   Vongpatanasin, Wanpen ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORTALIDONE; DIURETIC AGENT; SPIRONOLACTONE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MALE; MUSCLE CONTRACTION; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SYMPATHETIC NERVE;

RATTUS;

EID: 65249137181     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2660     Document Type: Article

References (39)

1. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) 2002 Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA 288:2981-2997
2. Xie F, Petitti DB, Chen W 2005 Prescribing patterns for antihypertensive drugs after the antihypertensive and lipid-lowering treatment to prevent heart attack trial: report of experience in a health maintenance organization. Am J Hypertens 18:464-469
3. Carter BL, Ernst ME, Cohen JD 2004 Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 43:4-9
4. Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJ, Phillips BB, Zimmerman MB, Bergus GR 2006 Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47:352-358
5. Aoki VS, Brody MJ 1969 The effect of thiazide on the sympathetic nervous system of hypertensive rats. Arch Int Pharmacodyn 177:423-434
6. Roos JC, Boer P, Koomans HA, Geyskes GG, Dorhout Mees EJ 1981 Haemodynamic and hormonal changes during acute and chronic diuretic treatment in essential hypertension. Eur J Clin Pharmacol 19:107-112
7. Ouzan J, Perault C, Lincoff AM, Carre E, Mertes M 2002 The role of spironolactone in the treatment of patients with refractory hypertension. Am J Hypertens 15:333-339
8. Nishizaka MK, Zaman MA, Calhoun DA2003 Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 16:925-930
9. Chapman N, Dobson J, Wilson S, Dahlof B, Sever PS, Wedel H, Poulter NR 2007 Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 49:839-845
10. Sharabi Y, Adler E, Shamis A, Nussinovitch N, Markovitz A, Grossman E 2006 Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension. Am J Hypertens 19:750 -755
11. Brody MJ, Varner KL, Vasquez EC, Lewis SJ 1991 Central nervous system and the pathogenesis of hypertension. Hypertension 18(Suppl 5):III7-III12
12. Rahmouni K, Barthelmebs M, Grima M, Imbs J-L, De Jong W 2001 Involvement of brain mineralocorticoid receptor in salt-enhanced hypertension in spontaneously hypertensive rats. Hypertension 38:902-906
13. Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, Felder RB 2001 Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol 281:H2241-H2251
14. Valbo AB, Hagbarth KE, Toreebjork HE, Wallin BG 1979 Somatosensory proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev 59:919-957
15. Leimbach Jr WN, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL 1986 Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73:913-919
16. Abate NI, Mansour YH, Tuncel M, Arbique D, Chavoshan B, Kizilbash A, Howell-Stampley T, Vongpatanasin W, Victor RG 2001 Overweight and sympathetic overactivity in Black Americans. Hypertension 38:379-383
17. Halliwill JR 2000 Segregated signal averaging of sympathetic baroreflex responses in humans. J Appl Physiol 88:767-773
18. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. JClin Endocrinol Metab 85:2402-2410
19. Wallace TM, Levy JC, Matthews DR 2004 Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
21. Grassi G, Seravalle G, Bertinieri G, Turri C, Dell'Oro R, Stella ML, Mancia G 2000 Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly. J Hypertens 18:587-593
22. Grassi G, Dell'Oro R, Seravalle G, Foglia G, Trevano FQ, Mancia G 2002 Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension. Circulation 106:1957-1961
23. Grassi G, Seravalle G, Dell'Oro R, Trevano FQ, Bombelli M, Scopelliti F, Facchini A, Mancia G 2003 Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. J Hypertens 21:1761-1769
24. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO 1993 Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 21:618 -623
25. Sartori C, Trueb L, Nicod P, Scherrer U 1999 Effects of sympathectomy and nitric oxide synthase inhibition on vascular actions of insulin in humans. Hypertension 34:586-589
26. Lembo G, Capaldo B, Rendina V, Iaccarino G, Napoli R, Guida R, Trimarco B, Sacca L 1994 Acute noradrenergic activation induces insulin resistance in human skeletal muscle. Am J Physiol 266:E242-E247
27. Navegantes LC, Sjostrand M, Gudbjornsdottir S, Strindberg L, Elam M, Lonnroth P 2003 Regulation and counterregulation of lipolysis in vivo: different roles of sympathetic activation and insulin. J Clin Endocrinol Metab 88:5515-5520
28. Helderman JH, Elahi D, Andersen DK, Raizes GS, Tobin JD, Shocken D, Andres R 1983 Prevention of the glucose tolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32:106 -111
29. Rowe JW, Tobin JD, Rosa RM, Andres R 1980 Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 29:498 -502
30. Siegel D, Saliba P, Haffner S 1994 Glucose and insulin levels during diuretic therapy in hypertensive men. Hypertension 23:688 -694
31. Ganie MA, Khurana ML, Eunice M, Gupta N, Gulati M, Dwivedi SN, Ammini AC 2004 Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study. J Clin Endocrinol Metab 89:2756-2762
32. Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi G, Novello M, Favret G, Melis A, Cavarape A, Sechi LA 2006 Insulin sensitivity in patients with primaryaldosteronism: a follow-up study. JClin Endocrinol Metab 91:3457-3463
33. Corbould A 2007 Effects of spironolactone on glucose transport and interleukin-6 secretion in adipose cells ofwomen. Horm Metab Res 39:915-918
34. Campion J, Maestro B, Molero S, Davila N, Carranza MC, Calle C 2002 Aldo sterone impairs insulin responsiveness in U-937 human promonocytic cells via the downregulation of its own receptor. Cell Biochem Funct 20:237-245
35. Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, Rilli S, Boscaro M 2007Aldosteroneasakeymediatorofthecardiometabolicsyndromeinprimary aldosteronism: an observational study. J Hypertens 25:177-186
36. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL 1991 Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87:2246-2252
37. Scherrer U, Owlya R, Trueb L 1996 Sympathetic-nerve activity before and after resection of an insulinoma. N Engl J Med 335:1240-1242
38. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD 1995 Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 26:1257-1263
39. Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K 2000 Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 20:538-544